Effects of first-line diabetes therapy with biguanides, sulphonylurea and thiazolidinediones on the differentiation, proliferation and apoptosis of islet cell populations

D. Sarnobat, R. C. Moffett, P. R. Flatt, A. I. Tarasov

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Endocrinological Investigation
Early online date30 Jun 2021
Publication statusE-pub ahead of print - 30 Jun 2021


  • Oral hypoglycaemic agents
  • Streptozotocin-induced diabetes
  • alpha-cells
  • Beta-cell proliferation
  • Transdifferentiation

Cite this